ConductScience.org, home

Paper42458505

Multimodal magnetic resonance imaging in neuroblastoma chemotherapy: a narrative review.

Lu X and 2 others. World J Surg Oncol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Multimodal magnetic resonance imaging in neuroblastoma chemotherapy: a narrative review. Papers, record 42458505. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42458505

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multimodal magnetic resonance imaging in neuroblastoma chemotherapy: a narrative review.
PubMed
Journal
World J Surg Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu XXiao
2Liu ZZhao
3Hao YYuewen

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeuroblastomaMajor topic
Multimodal ImagingMajor topic
Magnetic Resonance ImagingMajor topic
Humans
Prognosis
Dynamic Contrast Enhanced Magnetic Resonance Imaging
Diffusion Magnetic Resonance Imaging

Source PubMed

Download CSV of topics

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135401536Using a Gene Network of Pyroptosis to Quantify the Responses to Immunotherapy and Prognosis for Neuroblastoma Patients.Front Immunol2022https://conductscience.org/library/papers/35401536PubMed
231163505Update on Whole-body MRI in Musculoskeletal Applications.Semin Musculoskelet Radiol2019https://conductscience.org/library/papers/31163505PubMed
326761540MIBG in Neuroblastoma Diagnostic Imaging and Therapy.Radiographics2016https://conductscience.org/library/papers/26761540PubMed
437150742Outcomes and Histological Variations of Neuroblastoma and Ganglioneuroblastoma with Paraneoplastic Syndromes.Am Surg2023https://conductscience.org/library/papers/37150742PubMed
528471719Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.J Clin Oncol2017https://conductscience.org/library/papers/28471719PubMed
634156482[Radiological imaging of neuroblastoma].Radiologe2021https://conductscience.org/library/papers/34156482PubMed
729110068Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.Eur J Nucl Med Mol Imaging2018https://conductscience.org/library/papers/29110068PubMed
812195491MRI-diffusion imaging of neuroblastomas: first results and correlation to histology.Eur Radiol2002https://conductscience.org/library/papers/12195491PubMed
934462986Differentiating Benign from Malignant Renal Tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists.J Magn Reson Imaging2022https://conductscience.org/library/papers/34462986PubMed
1039702399GD2-targeted theranostics of neuroblastoma with [64Cu]Cu/[177Lu]Lu-hu3F8.Eur J Nucl Med Mol Imaging2025https://conductscience.org/library/papers/39702399PubMed
1125519453Variations in apparent diffusion coefficient values following chemotherapy in pediatric neuroblastoma.Diagn Interv Radiol2015https://conductscience.org/library/papers/25519453PubMed
1230701332Quantitative DWI predicts event-free survival in children with neuroblastic tumours: preliminary findings from a retrospective cohort study.Eur Radiol Exp2019https://conductscience.org/library/papers/30701332PubMed
1332196144Magnetic Nanoparticles in Cancer Therapy and Diagnosis.Adv Healthc Mater2020https://conductscience.org/library/papers/32196144PubMed
1434167847Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach.Semin Diagn Pathol2022https://conductscience.org/library/papers/34167847PubMed
1535435953Immunotherapy of Neuroblastoma: Facts and Hopes.Clin Cancer Res2022https://conductscience.org/library/papers/35435953PubMed
1635689207Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells.Mol Cancer2022https://conductscience.org/library/papers/35689207PubMed
1738039964ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells.Cancer Cell2023https://conductscience.org/library/papers/38039964PubMed
1838146213MR Imaging of Pediatric Neuroblastoma: Is Gadolinium Enhancement Necessary for Evaluation of Image-Defined-Risk Factors?Can Assoc Radiol J2024https://conductscience.org/library/papers/38146213PubMed
1936240450The role of ADC value and Ki-67 index in predicting the response to neoadjuvant chemotherapy in advanced stages of olfactory neuroblastoma.Br J Radiol2022https://conductscience.org/library/papers/36240450PubMed
2039189819Harnessing the therapeutic potential of phytochemicals in neuroblastoma.Biofactors2025https://conductscience.org/library/papers/39189819PubMed

See all 102 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42458505

GET https://conductscience.org/api/papers/v1/42458505/references?page=2